Microparticle Formation and Platelet Shrinkage in Type-I Glanzmman Thrombasthenia Platelets

Journal Title: Iranian Journal of Blood and Cancer - Year 2014, Vol 6, Issue 4

Abstract

Background: Activated normal platelets undergo many biochemical and morphological changes, some of which are apoptotic. Platelet derived microparticles and shrinked platelets as hallmark of platelet activation and apoptosis disperse surfaces containing procoagulant activity around injured vessels and tissues. This study was conducted to determine microparticles formation and platelet shrinkage in Glanzmann thrombasthenia upon activation. Patients and Methods: Platelets from twelve unrelated type I Glanzmann thrombasthenia patients were examined as washed platelets. Calcium ionophore A23187 was used as agonist to activate the platelets. Flow cytometry was applied to measure platelet-derived micro particles (forward scatter events <1.0 µm size), and platelet shrinkage (mean-FSC). Anti-CD42b was used as platelet specific marker to distinguish platelets from other likely particles. Annexin A5 Alexa Fluor was used to determine phosphatidylserine exposure and confirm platelet activation and apoptosis. Results: Calcium ionophore A23187, dramatically increased MP formation by type-I GT platelets up to 14.5 fold increase over baseline (Buffer treated: 14.18 ± 5.4% vs. A23187 treated: 34.31 ± 15.2% p<0.005). Also calcium ionophore A23187, increased platelet shrinkage by type-I GT platelets and mean-FSC decreased (Buffer treated: 4.12±1.3 vs. A23187 treated: 1.67±0.2 p<0.0024). Conclusion: This study showed that, type I Glanzmann thrombasthenia platelets demonstrate platelet apoptosis considering two apoptotic targets, including micro particles formation and platelet shrinkage. We conclude that in thrombasthenic Glanzmann platelets at least some aspects of normal apoptosis is ongoing, and this may explain normal platelet count among these patients. Keywords: Apoptosis, Glanzmann thrombasthenia, glycoprotein IIbIIIa, flow cytometry, microparticle.

Authors and Affiliations

T Hemmati, A Farsinezhad, MR Managhchi, G Toogeh, M Faranoush

Keywords

Related Articles

Incidence and Pattern of Childhood Leukaemia in Basrah, Iraq during 2003-2007

Background: Environment of Basrah is seriously contaminated with chemical leukomogens as a result of recent military conflicts. Many studies in the past few years have reported an increase in the incidence of leukemia in...

Rhabdomyosarcoma of Eyelid: A picture presentation

This is a picture review of a case of orbital rhabdomyosarcoma. The course of patients diagnosis, treatment and outcome is briefly presented.

Evaluating Blood Requests and Transfusion Practice in Major Surgical Procedures

Background: Red blood cell and other blood products play a crucial role in management of different disease processes, but in spite of implementation of crucial steps to improve the process of request for blood and blood...

The First Discrete Choice Experiment On Usage of Bypassing Agents in Hemophilic Patients in Iran

Background: Bleeding events in hemophilic patients with inhibitors are managed by bypassing agents. Currently available agents in Iran are recombinant activated factor VII (rfVIIa; Aryogen, Aryoseven) and Feiba (factor e...

Download PDF file
  • EP ID EP363425
  • DOI -
  • Views 78
  • Downloads 0

How To Cite

T Hemmati, A Farsinezhad, MR Managhchi, G Toogeh, M Faranoush (2014). Microparticle Formation and Platelet Shrinkage in Type-I Glanzmman Thrombasthenia Platelets. Iranian Journal of Blood and Cancer, 6(4), 169-175. https://europub.co.uk./articles/-A-363425